EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial

Wouter M Sluis iD, Jeroen C de Jonge iD, Hendrik Reinink, Alastair Wilson, Lisa J Woodhouse iD, Jesse Dawson iD, Kennedy R Lees, Philip M Bath, Hendrik Bart van der Worp iD

European Stroke Journal · 2025

DOI: 10.1177/23969873251320207 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Stroke Journal, 2025. Verfasst von Wouter M Sluis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The modified Rankin Scale (mRS) is the most frequently used primary outcome measure in acute stroke research despite significant interobserver variability in assigning grades. We assessed the use of central blinded adjudication of the mRS based on a video recording of an interview in the PRECIOUS trial. Patients and methods PRECIOUS was an international, randomized, open-label, clinical trial with blinded outcome assessment of preventive treatment with metoclopramide, paracetamol, and ceftriaxone in elderly patients with acute stroke. Trained local investigators interviewed patients or their representatives and graded functional outcome at 90 days after stroke with the mRS. In each participating country, a video recording of the interview was assessed by three blinded, independent adjudicators. The primary outcome of the present substudy was interobserver agreement between the local mRS score and the median score of the three central adjudicators for patients alive at 90 days, assessed with Cohen’s kappa and quadratic weighted kappa statistics. The difference between treatment effect estimates based on local and central adjudication was a secondary outcome.

Results

Of 1493 patients enrolled in PRECIOUS, 1471 were included in this analysis. At 90 days, 1117 patients (75.9%) were alive and had both a central and local assessment; 28 participants did not have a central mRS score. Interobserver agreement was seen in 829 (74.2%) patients and was substantial (kappa of 0.68; 95% CI 0.65–0.71). Disagreement occurred more often in patients with a central mRS score of 0–2 (OR 2.24; 95% CI 1.14–4.24). Treatment effects were neutral for all three study drugs and did not differ between central and local adjudication. Discussion and conclusion Central adjudication of the mRS based on a video recording is feasible in a large international, randomized stroke trial. This ensures blinding of the outcome assessment. In this neutral trial, the impact of central adjudication on the precision of effect size estimates could not be assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeHumansMaleFemaleAgedMetoclopramideAged, 80 and overObserver VariationAcetaminophenCeftriaxoneTreatment OutcomeMiddle AgedOutcome Assessment, Health Care

Stichwörter der Autor:innen

Ischemic strokePRECIOUSaspirationinterobserver variabilityintracerebral hemorrhagemodified Rankin Scalepneumoniarandomized trial

Substanzen

MetoclopramideAcetaminophenCeftriaxone

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Department of Neurology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Department of Neurology, Spaarne Gasthuis, Haarlem, The Netherlands.
  • School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
  • Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, UK.
  • Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

ORCID-Profile: Wouter M Sluis, Jeroen C de Jonge, Lisa J Woodhouse, Jesse Dawson, Hendrik Bart van der Worp

Förderung

  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Sluis, W. M., de Jonge, J. C., Reinink, H., Wilson, A., Woodhouse, L. J., Dawson, J., Lees, K. R., Bath, P. M., & van der Worp, H. B. (2025). Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial. European Stroke Journal. https://doi.org/10.1177/23969873251320207

Vancouver

Sluis WM, de Jonge JC, Reinink H, Wilson A, Woodhouse LJ, Dawson J, et al. Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial. European Stroke Journal. 2025. doi:10.1177/23969873251320207

BibTeX
@article{Sluis2025,
  author = {Sluis, Wouter M and de Jonge, Jeroen C and Reinink, Hendrik and Wilson, Alastair and Woodhouse, Lisa J and Dawson, Jesse and Lees, Kennedy R and Bath, Philip M and van der Worp, Hendrik Bart},
  title = {Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial},
  journal = {European Stroke Journal},
  year = {2025},
  doi = {10.1177/23969873251320207}
}
Kostenlos starten →